NATH BIOGENES (INDIA)
Back to All Ratios
|
NATH BIOGENES (INDIA) Last 5 Year Cash Earnings per Share (CEPS) History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2013 | |
|---|---|---|---|---|---|
| CEPS(Rs) | 22.32 | 22.56 | 20.01 | -33.84 | 10.16 |
What is the latest Cash Earnings per Share (CEPS) ratio of NATH BIOGENES (INDIA) ?
| Year | Cash Earnings per Share (CEPS) |
|---|---|
| Mar2025 | 22.32 |
| Mar2024 | 22.56 |
| Mar2023 | 20.01 |
| Mar2022 | -33.84 |
| Mar2013 | 10.16 |
How is Cash Earnings per Share (CEPS) of NATH BIOGENES (INDIA) Trending?
| Years | Cash Earnings per Share (CEPS) | % Change | |
|---|---|---|---|
| Mar2025 | 22.32 | -1.06 | |
| Mar2024 | 22.56 | 12.74 | |
| Mar2023 | 20.01 | Positive | |
| Mar2022 | -33.84 | Negative | |
| Mar2013 | 10.16 | - | |
Other Financial Ratios of NATH BIOGENES (INDIA)
| Operational & Financial Ratios Earnings Per Share DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Cash Earnings per Share (CEPS) ratio of peers of NATH BIOGENES (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NATH BIOGENES (INDIA) | ₹330.2 Cr | 18.3% | 19% | 9.7% | Stock Analytics | |
| BOMBAY BURMAH TRADING CORPORATION | ₹10,440.7 Cr | 1.6% | -5% | -14.6% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹4,760.9 Cr | 2.4% | 15.7% | -31.2% | Stock Analytics | |
| VENKYS (INDIA) | ₹2,111.8 Cr | 2.9% | 16.4% | -6.7% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹1,077.6 Cr | -4.7% | 23.2% | -15.5% | Stock Analytics | |
| INDO US BIOTECH | ₹214.6 Cr | 1.2% | 7.8% | -32.4% | Stock Analytics | |
NATH BIOGENES (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NATH BIOGENES (INDIA) | 18.3% |
19% |
9.7% |
| SENSEX | 4.7% |
-0.1% |
3.6% |
You may also like the below Video Courses